Frank Rimerman Advisors LLC Trims Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Frank Rimerman Advisors LLC trimmed its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,588 shares of the pharmacy operator’s stock after selling 2,350 shares during the period. Frank Rimerman Advisors LLC’s holdings in Walgreens Boots Alliance were worth $155,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of WBA. State Street Corp increased its stake in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after buying an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after buying an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth $24,226,000. Amundi increased its stake in Walgreens Boots Alliance by 70.3% in the 4th quarter. Amundi now owns 4,455,720 shares of the pharmacy operator’s stock worth $41,082,000 after buying an additional 1,839,045 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at about $9,685,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 0.3 %

Shares of NASDAQ WBA opened at $11.26 on Tuesday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The company has a market cap of $9.73 billion, a P/E ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.05. The firm has a 50-day simple moving average of $10.86 and a two-hundred day simple moving average of $9.77.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the firm earned $0.66 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on WBA shares. Royal Bank of Canada raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Finally, Bank of America raised their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.